Myoview™

Myoview™ 30 mL (Kit for the Preparation of Technetium Tc-99m Tetrofosmin for Injection) is indicated for myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease. Myoview is also indicated for the assessment of left ventricular function (left ventricular ejection fraction and wall motion) in patients with known or suspected heart disease.

15-minute start time to image acquisition enables efficient protocol for stress and rest imaging

Bringing new product offerings and technologies to market is a critical part of our mission to help elevate the practice of nuclear cardiology. Our ongoing commitment to innovate and invest in both current and future SPECT/PET imaging products, is rooted in our promise to consistently strive to deliver better outcomes for clinicians and their patients.

Currently available SPECT tracers, such as Myoview™ 30 mL (Kit for the Preparation of Technetium (Tc-99m Tetrofosmin for Injection) as well as investment in the development of next generation imaging agents, serve important roles in assisting with patient diagnostics and management of cardiovascular disease – both now and in the future.

1. Myoview [prescribing information]. Arlington Heights, IL: GE Healthcare; 2017.
2. Ravizzini GC, Hanson MW, Shaw LK, et al. Nucl Med Comm. 2002;23:203-208. Erratum in April 2006.